TrialJournal of the National Cancer Institute2021

Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study.

Leisha A Emens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.